A 45-year-old man with obesity and dyslipidaemia presents for cardiovascular risk assessment. He is a non-smoker, has no diabetes and no history of cardiovascular disease. His fasting lipids show LDL cholesterol 4.2 mmol/L, HDL 0.9 mmol/L and triglycerides 2.1 mmol/L. His 10-year Framingham risk is calculated at 18%. According to Canadian dyslipidaemia guidance, what is the most appropriate management?